UiPath’s AI Automation Story Is Not Translating Into Faster Growth Yet, Say UBS, Morgan Stanley Analysts
Analysts at UBS reduced their price target for UiPath stock to $13 from $17 while maintaining a ‘Neutral’…
Browsing Tag